Altana

Last updated

ALTANA AG
Type Aktiengesellschaft
Industry Chemicals
Founded1977
Founder Herbert Quandt
Headquarters,
Key people
  • Martin Babilas, CEO [1]
  • Dr. Matthias L. Wolfgruber, Chair, Supervisory Board [2]
  • Susanne Klatten - sole owner and deputy chairman [3]
Revenue 3 billion (2022) [4]
Number of employees
8,000 (2024) [5]
Subsidiaries
Website www.altana.com

Altana AG (styled as ALTANA) is a German chemical company headquartered in Wesel. It was created in 1977, as a result of spinning off divisions from the Varta Group. [6] The first CEO was Herbert Quandt.

Contents

The group comprises the divisions BYK (coating additives and instruments), Eckart (metal effect pigments and metallic printing inks), Elantas (insulation materials for the electrical and electronics industries) and Actega (coatings and sealant compounds for the packaging industry).

The Altana Group has 48 production facilities and 63 service and research laboratories worldwide. In 2022, the company, with about 7,000 employees, posted revenues of over €3 billion. [4]

History

Altana's roots go back to 1873, when Heinrich Byk founded the chemicals factory Dr. Heinrich Byk Chemische Fabrik in Oranienburg. The company grew, and in 1931, it was renamed BYK-Gulden Lomberg. In 1941, majority control of the company was acquired by AFA (Akkumulatoren-Fabrik AG) which was renamed VARTA in 1962. In 1977, VARTA was split into three companies, one of which was Altana. [7]

From 1977 to 2010, Altana was publicly traded on the Frankfurt Stock Exchange. Altana was also admitted to trading on the New York Stock Exchange from 2002 to 2007.

On 19 December 2006, the majority of shareholders voted to approve the sale of the pharmaceuticals division to the Danish company Nycomed. [8] Nycomed is owned by an investment consortium led by Nordic Capital and Credit Suisse. With the sale of the pharmaceuticals division, headquartered in Konstanz, Germany, Altana lost a major pillar of its business. At that time, 9,000 of the company's 13,500 employees were working for Altana in the pharmaceuticals sector, generating two-thirds of the company's total revenue. And indeed, the balance-sheet revenues fell by around 60 percent in 2006, but gained over six percent in 2007.

The patent for pantoprazole, a stomach ulcer and reflux treatment drug, the main revenue-generator for the former pharmaceuticals division, expired in 2009/2010. While the Altana Management Board justified the divestiture of the pharmaceutical business with delays in the approval of new products, increased research and development costs as well as strict regulatory requirements in the US and Europe, shareholder activists asserted that the management board had invested too little in the pharmaceutical business in the preceding years and had failed to develop successor products in time to compensate for the revenue losses to be expected due to the expiry of the pantaprazole patent at the end of the decade.

The pharmaceuticals division was sold for €4.6 billion. The entire proceeds from the sale were disbursed to the shareholders, who received a special dividend of €33 per share. Critics expressed discontent that the main shareholder benefited most from the sale of the pharmaceuticals division.

Until 1 January 2007, the company was organized into the pharmaceuticals division Altana Pharma AG, formerly Byk Gulden Lomberg Chemische Fabrik, headquartered in Konstanz, and the specialty chemicals division Altana Chemie AG based in Wesel. Since the sale of the pharmaceutical business to Nycomed, Altana has been operating exclusively in the specialty chemicals segment. This restructuring was accompanied by a change in the company logo, which was unified across all subsidiaries.

On 6 November 2008, main shareholder SKion GmbH (Germany, owned by Susanne Klatten) issued a public takeover offer of €13 per share for all outstanding shares, an action which drove up the stock price. [9] A company spokesperson stated that the intention was to delist the company from public trading. To achieve this, SKion issued a second takeover offer of €14 per share to the remaining shareholders on 9 November 2009. [10]

On 30 December 2008, the Frankfurt Stock Exchange announced that Altana would be removed from its MDAX index, as the increase in the share held by SKion had pushed the portion of stock held in free float to under ten percent. By June 2010, SKion held 95.04 percent of all shares.

In Germany, the stock was traded mainly on the Frankfurt and Stuttgart Exchanges and the Xetra platform; internationally, it was admitted to trading on the London Stock Exchange and the NASD Group, now FINRA, in the US.

After SKion acquired the entire Altana stock through a squeeze-out, trading in this stock was suspended effective 27 August 2010.

Related Research Articles

<span class="mw-page-title-main">IG Farben</span> Former German chemicals conglomerate

I. G. Farbenindustrie AG, commonly known as IG Farben, was a German chemical and pharmaceutical conglomerate. It was formed in 1925 from a merger of six chemical companies: BASF, Bayer, Hoechst, Agfa, Chemische Fabrik Griesheim-Elektron, and Chemische Fabrik vorm. Weiler Ter Meer. It was seized by the Allies after World War II and split into its constituent companies; parts in East Germany were nationalized.

Sandoz Group AG is a Swiss-Germany based company that focuses on generic pharmaceuticals and biosimilars. Prior to October 2023, it was part of a division of Novartis that was established in 2003, when Novartis united all of its generics businesses under the name Sandoz. Before this, the company existed as an independent pharmaceutical manufacturer until 1996, when it was merged with Ciba-Geigy to form the company Novartis. Prior to the merger, it specialized in medicines used in organ transplants, such as Sandimmune, and various antipsychotics and migraine medicines. Its headquarters were in Holzkirchen, Germany and after the spin-off from Novartis, the headquarters moved to Basel, Switzerland. Sandoz is one of the leading global generics business.

<span class="mw-page-title-main">Ciba Specialty Chemicals</span> Swiss chemical company

Ciba was a chemical company based in and near Basel, Switzerland. "Ciba" stood for "Chemische Industrie Basel" and was formed when the non-pharmaceuticals elements of Novartis were spun out in 1997, following the merger in the previous year of Ciba-Geigy and Sandoz that created Novartis.

<span class="mw-page-title-main">Susanne Klatten</span> German businesswoman

Susanne Hanna Ursula Klatten is a German billionaire heiress, the daughter of Herbert and Johanna Quandt. As of January 2022, her net worth was estimated at US$23.4 billion, and the richest woman in Germany and the 50th richest person in the world according to the Bloomberg Billionaires Index.

<span class="mw-page-title-main">Schering AG</span>

Schering AG was a research-centered German multinational pharmaceutical company headquartered in Wedding, Berlin, which operated as an independent company from 1851 to 2006. In 2006, it was bought by Bayer AG and merged to form the Bayer subsidiary Bayer Schering Pharma AG, which was renamed Bayer HealthCare Pharmaceuticals in 2011. Schering was listed on the Frankfurt Stock Exchange and had 26,000 employees as of 2004.

Herbert Werner Quandt was a German industrialist and member of the Nazi Party credited with having saved BMW when it was at the point of bankruptcy and made a huge profit in doing so. Quandt also oversaw the use at his family's factories during World War II of tens of thousands of slave labourers, many of whom perished.

<span class="mw-page-title-main">Günther Quandt</span> German businessman

Günther Quandt was a German industrialist who founded an industrial empire that today includes BMW and Altana, a car and chemical company, respectively. Between, 1921 and 1929 he was married to Magda Ritschel, later the wife of Nazi Propaganda Minister Joseph Goebbels. In the 1930s he joined the Nazi Party, becoming one of its strong financial supporters.

<span class="mw-page-title-main">VARTA</span> German electrical battery manufacturer

VARTA AG is a German company manufacturing batteries for global automotive, industrial, and consumer markets.

<span class="mw-page-title-main">K+S</span>

K+S AG is a German chemical company headquartered in Kassel. The company is Europe’s largest supplier of potash for use in fertilizer. The firm also produces and distributes other mineral fertilizers, such as those from magnesium and sulfur. K+S is mainly active in Europe, North and South America with almost 15,000 employees worldwide (2020).

<span class="mw-page-title-main">Cassella</span> German chemical and dye company

Cassella AG, formerly Leopold Cassella & Co. and Cassella Farbwerke Mainkur AG, commonly known as Cassella, was a German chemical and pharmaceutical company with headquarters in Frankfurt am Main. Founded in 1798, in the Frankfurt Jewish Alley by Leopold Cassella, Cassella operated as an independent company until 1995, and was one of many predecessor companies of today's Sanofi. Its main products were dyes, drugs, cosmetics and various other chemical products. From 1949, Cassella focused increasingly on pharmaceuticals and cosmetics rather than its former primary focus, dyes. Much of its history is closely associated with the Gans family, a prominent family of industrialists and philanthropists and former owners of Cassella.

<span class="mw-page-title-main">Chemische Fabrik Kalk</span>

Chemische Fabrik Kalk (CFK) was a German chemicals company based in Kalk, a city district of Cologne. The company was founded in 1858 as Chemische Fabrik Vorster & Grüneberg, Cöln by Julius Vorster and Hermann Julius Grüneberg and was renamed to Chemische Fabrik Kalk GmbH in 1892. At times the company was the second-largest German producer of soda ash and was, with almost 2400 employees, one of the largest employers in Cologne. For decades the chimneys and the water tower of the factory dominated the skyline of Cologne-Kalk.

<span class="mw-page-title-main">Laporte plc</span>

Laporte plc was a leading British chemicals business that operated from 1888 to 2000. It was listed on the London Stock Exchange and was a constituent of the FTSE 100 Index.

<span class="mw-page-title-main">Eugen de Haën</span> German chemist and entrepreneur (1835–1911)

Carl Johann Eugen de Haën, often known as Eugen de Haën or Eugen de Haen, was a German chemist and entrepreneur. He was founder of the chemistry factory E. de Haën & Co.

<span class="mw-page-title-main">Wilhelm Schuler</span> German chemist (1914–2010)

Wilhelm Alfons Schuler was a chemist, inventor and entrepreneur in the second half of the 20th century.

<span class="mw-page-title-main">Nycomed</span> Swiss pharmaceutical company

Nycomed is a Swiss pharmaceutical company. Nycomed was acquired by Takeda Pharmaceuticals in September 2011. Production was located in Norway, Denmark, Poland, Austria, Belgium, Germany, Estonia, India, Mexico, Brazil and Argentina. Head office is located in Zürich, Switzerland. Total revenue was €3,400 million in 2006 and the group had 12,000 employees then. The company awarded an annual prize totaling 20,000 euros to four excellent junior scientists at the University of Konstanz. Also, the award promoted the concept of scientific exchange and networking of its winners.

DVB BankSE is part of the DZ BANK Group and a specialist in international transportation finance, based in Frankfurt/Main, Germany.

<span class="mw-page-title-main">Sachtleben Chemie</span>

Sachtleben Chemie is a chemicals producer, with its primary focus on the production of white pigments, fillers and extenders. The company employs some 2,200 persons and achieves annual sales of around 820 million euros (2012). Sachtleben has been a member of the multinational Venator group since 2017. The company's corporate history reaches back over 130 years. Sachtleben produces particles using titanium dioxide, zinc sulfide and barium sulfate as the chemical basis, and markets these products worldwide. The principal applications for Sachtleben products include man-made fibers, paints and other coatings, plastics, and paper. Sachtleben also supplies special particles to the foodstuffs, pharmaceuticals and cosmetics industries, and has interests in the fields of chromatography, nanotechnology, catalysis, and the production of building materials. The company leads the world in special titanium dioxide grades for printing inks and for the cosmetics, pharmaceuticals and food industries. The production facilities at all three locations apply the sophisticated sulfate-route process.

<span class="mw-page-title-main">Atotech</span>

Atotech is an international speciality chemicals and equipment company. It provides chemistry and equipment for companies that manufacture printed circuit boards, IC-substrates and semiconductors; and also provides specialty chemicals and equipment for decorative and functional surface finishing in the automotive, construction, furniture and other industries.

<span class="mw-page-title-main">CIECH</span> Polish chemical industry group

CIECH S.A., is a Polish chemical company headquartered in Warsaw and one of the leading companies in the European chemical industry. The CIECH Group was founded in Łódź, Poland in 1945 and currently consists of 8 manufacturing sites, in addition to trade and service businesses. Its annual revenue places the company among the top fifty Polish companies.

BYK is a globally operating supplier of additives and measuring instruments.

References

  1. AG, ALTANA. "Martin Babilas - ALTANA AG". www.altana.com. Archived from the original on 1 October 2018. Retrieved 6 January 2016.
  2. AG, ALTANA. "Supervisory Board - ALTANA AG". www.altana.com. Archived from the original on 8 March 2019. Retrieved 27 March 2014.
  3. "Forbes". Forbes . Retrieved 8 November 2019.
  4. 1 2 "Altana Corporate Report 2022" Archived 30 December 2017 at the Wayback Machine , altana.com. Retrieved 31 December 2019.
  5. AG, ALTANA. "History - ALTANA AG". www.altana.com.
  6. "History". Altana AG. Retrieved 15 March 2017.
  7. "Global leader in true specialty chemicals - ALTANA AG". www.altana.com. Retrieved 27 February 2023.
  8. "boerse.ARD.de : Klatten will Altana ganz schlucken". 13 January 2010. Archived from the original on 13 January 2010. Retrieved 27 February 2023.
  9. "Skion strebt Squeeze-out bei Chemiekonzern Altana an". Archived from the original on 15 August 2011. Retrieved 27 February 2023.